Surinabant Completed Phase 2 Trials for Smoking, Cessation Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00432575Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)